↓ Skip to main content

A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers Applicability of a novel insulin-independent treatment

Overview of attention for article published in Diabetes Care, June 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

policy
2 policy sources
patent
4 patents

Citations

dimensions_citation
326 Dimensions

Readers on

mendeley
133 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers Applicability of a novel insulin-independent treatment
Published in
Diabetes Care, June 2009
DOI 10.2337/dc09-0517
Pubmed ID
Authors

John P.H. Wilding, Paul Norwood, Caroline T'joen, Arnaud Bastien, James F. List, Fred T. Fiedorek

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 133 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
India 1 <1%
Ireland 1 <1%
Brazil 1 <1%
Unknown 129 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 21 16%
Researcher 17 13%
Other 16 12%
Student > Master 15 11%
Student > Ph. D. Student 12 9%
Other 21 16%
Unknown 31 23%
Readers by discipline Count As %
Medicine and Dentistry 53 40%
Agricultural and Biological Sciences 15 11%
Pharmacology, Toxicology and Pharmaceutical Science 8 6%
Biochemistry, Genetics and Molecular Biology 7 5%
Nursing and Health Professions 6 5%
Other 11 8%
Unknown 33 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 January 2022.
All research outputs
#2,863,557
of 25,371,288 outputs
Outputs from Diabetes Care
#3,434
of 10,600 outputs
Outputs of similar age
#10,354
of 124,070 outputs
Outputs of similar age from Diabetes Care
#21
of 66 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,600 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.5. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 124,070 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 66 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.